10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $267 | -74.6% | 6,474 | -65.6% | 0.00% | -71.4% |
| Q2 2023 | $1,050 | +75.3% | 18,797 | +75.1% | 0.01% | +75.0% |
| Q1 2023 | $599 | +97.7% | 10,733 | +29.0% | 0.00% | +100.0% |
| Q4 2022 | $303 | -99.9% | 8,320 | -30.4% | 0.00% | 0.0% |
| Q3 2022 | $341,000 | -42.9% | 11,960 | -9.4% | 0.00% | -50.0% |
| Q2 2022 | $597,000 | -50.8% | 13,200 | -17.2% | 0.00% | -33.3% |
| Q1 2022 | $1,213,000 | -46.7% | 15,948 | +4.5% | 0.01% | -40.0% |
| Q4 2021 | $2,274,000 | +32.4% | 15,267 | +29.4% | 0.01% | +11.1% |
| Q3 2021 | $1,717,000 | -5.5% | 11,796 | +27.2% | 0.01% | -10.0% |
| Q2 2021 | $1,816,000 | +49.8% | 9,276 | +38.5% | 0.01% | +42.9% |
| Q1 2021 | $1,212,000 | +57.0% | 6,698 | +22.8% | 0.01% | +40.0% |
| Q4 2020 | $772,000 | +53.2% | 5,454 | -45.5% | 0.01% | +25.0% |
| Q3 2019 | $504,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |